Creative Medical Technology Holdings, Inc. (NasdaqCM:CELZ) announces a share repurchase program. Under the program, the company will repurchase up to $2 million worth of its outstanding common stock. The program has no expiry date.
Creative Medical Technology Holdings, Inc.
Equities
CELZ
US22529Y4089
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.59 USD | +4.06% |
|
-5.76% | -22.12% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.12% | 4.65M | |
+20.12% | 127B | |
+25.25% | 117B | |
+25.56% | 27.77B | |
-19.51% | 20.44B | |
-14.36% | 16.62B | |
-15.63% | 15.92B | |
-46.67% | 14.94B | |
+11.89% | 14.74B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- CELZ Stock
- News Creative Medical Technology Holdings, Inc.
- Creative Medical Technology Holdings, Inc. announces an Equity Buyback for $2 million worth of its shares.